Lanzhou Foci Pharmaceutical Co (SZSE:002644) EBIT per Share : ¥0.10 (TTM As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co EBIT per Share?

Lanzhou Foci Pharmaceutical Co's EBIT per Share for the three months ended in Sep. 2024 was ¥0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.10.

During the past 12 months, the average EBIT per Share Growth Rate of Lanzhou Foci Pharmaceutical Co was -39.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was 20.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 16.40% per year. During the past 10 years, the average EBIT per Share Growth Rate was 17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Lanzhou Foci Pharmaceutical Co's EBIT per Share or its related term are showing as below:

SZSE:002644' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.7 Med: 4.95 Max: 48.4
Current: 20.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Lanzhou Foci Pharmaceutical Co was 48.40% per year. The lowest was -19.70% per year. And the median was 4.95% per year.

SZSE:002644's 3-Year EBIT Growth Rate is ranked better than
68.28% of 826 companies
in the Drug Manufacturers industry
Industry Median: 8.15 vs SZSE:002644: 20.60

Lanzhou Foci Pharmaceutical Co's EBIT for the three months ended in Sep. 2024 was ¥4.4 Mil.

Lanzhou Foci Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Lanzhou Foci Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanzhou Foci Pharmaceutical Co EBIT per Share Chart

Lanzhou Foci Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.16

0.26

0.22

0.26

0.16

Lanzhou Foci Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.01	0.01	0.07	0.02	0.01

Lanzhou Foci Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Lanzhou Foci Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	82.883	/	510.560
=	0.16

Lanzhou Foci Pharmaceutical Co's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	4.438	/	511.189
=	0.01

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.10

Lanzhou Foci Pharmaceutical Co (SZSE:002644) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Lanzhou Foci Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Lanzhou Foci Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lanzhou Foci Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046

Website

http://www.fczy.com

Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australia, Russia, and Ukraine, among others.

Executives

Sun Yu	Directors, executives
Su Wen Bo	Supervisors
An Wen Ting	Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines